137 related articles for article (PubMed ID: 9378386)
1. K-ras mutations in patients with early colorectal cancers.
Andreyev HJ; Tilsed JV; Cunningham D; Sampson SA; Norman AR; Schneider HJ; Clarke PA
Gut; 1997 Sep; 41(3):323-9. PubMed ID: 9378386
[TBL] [Abstract][Full Text] [Related]
2. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
3. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
4. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
5. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
Losi L; Benhattar J; Costa J
Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K
Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
[TBL] [Abstract][Full Text] [Related]
10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
11. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations and prognosis in large-bowel carcinomas.
Andersen SN; Løvig T; Breivik J; Lund E; Gaudernack G; Meling GI; Rognum TO
Scand J Gastroenterol; 1997 Jan; 32(1):62-9. PubMed ID: 9018769
[TBL] [Abstract][Full Text] [Related]
13. Ras oncogene activation in benign and malignant colorectal tumours.
Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma.
Etoh T; Ueo H; Inoue H; Sato K; Utsunomiya T; Barnard GF; Kitano S; Mori M
Ann Surg Oncol; 2001 Jun; 8(5):407-12. PubMed ID: 11407514
[TBL] [Abstract][Full Text] [Related]
15. Ki-ras mutations and prognosis in colorectal cancer.
Kressner U; Bjørheim J; Westring S; Wahlberg SS; Påhlman L; Glimelius B; Lindmark G; Lindblom A; Børresen-Dale AL
Eur J Cancer; 1998 Mar; 34(4):518-21. PubMed ID: 9713302
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer.
González-Aguilera JJ; Oliart S; Azcoita MM; Fernández-Peralta AM
Am J Clin Oncol; 2004 Feb; 27(1):39-45. PubMed ID: 14758132
[TBL] [Abstract][Full Text] [Related]
17. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
18. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
19. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
[TBL] [Abstract][Full Text] [Related]
20. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]